首页> 外国专利> Production of binding sites for PAF, PAF analogues and PAF antagonists in endothelial cells

Production of binding sites for PAF, PAF analogues and PAF antagonists in endothelial cells

机译:在内皮细胞中产生PAF,PAF类似物和PAF拮抗剂的结合位点

摘要

The invention refers to the production of substances which prevent and treat disorders caused by pathological cell differentiation leading to enhanced LA-paf effect and production. The invention refers to simple methods to test and produce LA-paf antagonists and paf antagonists against very high affinity paf receptors on endothelial cells. According to the invention genes producing endothelial paf receptors in endothelial cells during differentiation for example in response to insulin can be transferred from adherent endothelial cell lines to soluble cells. Endothelial cell lines for example immortalized endothelial cells can also be cultured on soluble particles for screening procedures. Substances which prevent and inhibit very high affinity paf receptors and LA-paf production antagonize pathological differentiation, irritation, aging and death of cells. The antagonists can be administered for example with food.
机译:本发明涉及预防和治疗由病理性细胞分化引起的导致LA-paf作用增强的疾病的物质的生产和生产。本发明涉及测试和生产针对内皮细胞上非常高亲和力paf受体的LA-paf拮抗剂和paf拮抗剂的简单方法。根据本发明,可以在分化过程中例如响应胰岛素而在内皮细胞中产生内皮paf受体的基因从粘附的内皮细胞系转移至可溶性细胞。内皮细胞系例如无限增殖的内皮细胞也可以在可溶性颗粒上培养用于筛选程序。预防和抑制非常高亲和力的paf受体和LA-paf产生的物质可拮抗细胞的病理分化,刺激,衰老和死亡。拮抗剂可以与例如食物一起施用。

著录项

  • 公开/公告号US5530023A

    专利类型

  • 公开/公告日1996-06-25

    原文格式PDF

  • 申请/专利权人 KORTH;RUTH;

    申请/专利号US19930172234

  • 发明设计人 RUTH KORTH;

    申请日1993-12-23

  • 分类号A61K31/34;

  • 国家 US

  • 入库时间 2022-08-22 03:38:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号